|
Borchardt H, Ewe A,
Morawski M, Weirauch U, Aigner A
miR24-3p activity after delivery into pancreatic carcinoma cell lines
exerts profound
tumor-inhibitory effects though distinct pathways of apoptosis and
autophagy induction
Cancer Lett. 2021; 503;174-184
Chai XN, Ludwig FA, Müglitz A,
Schaefer M, Yin HY,Brust O, Regenthal R,
Krügel U
Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor
SH045 (Larixyl N- methylcarbamate) and Its Application in an Exploratory
Pharmacokinetic Study in Mice
Pharmaceuticals (Basel) 2021; 14(3): 259
Entzian K, Aigner A
Drug Delivery by Utrasound-Responsive Nanocarriers for Cancer
Treatment.
Pharmaceutics 2021; 13(8): 1135
Gutsch D, Jenke R, Büch T,
Aigner A
Inhibition of HER Receptors Reveals Distinct Mechanisms of Compensatory
Upregulation of Other HER Family Members: Basis for Acquired Resistance
and for Combination Therapy
Cells 2021; 10(2): 272
Jenke R, Reißing
N, Hansen FK, Aigner A, Büch T
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination
Strategies and Future Perspectives.
Cancers (Basel) 2021; 13(4): 634
Karimov M, Appelhans D, Ewe
A, Aigner A
The combined disulfide cross-linking and tyrosine-modification of very
molecular weight linear PEI
synergistically enhances transfection efficacies and improves
biocompatibility.
Eur J Pharm Biopharm 2021; 161:56-65
Karimov M, Schulz M,Kahl
T, Noske S, Kubczak M, Gockel I, Thieme R, Büch
T, Reinert A,
Ionov M,Bryszewska M, Franke H, Krügel U, Ewe A,
Aigner A
Tyrosine-modified linear PEIs for highly efficacious and biocompatible
siRNA delivery in vitro and in vivo
Nanomedicine 2021; 36:102403
Regenthal R, Rong P,
Krügel U
Nutraceuticals in mental diseases - Bridging the gap between
traditional use and modern pharmacology.
Curr Opin Pharmacol 2021;Dec 61: 62-68
Schellenberg LM, Regenthal R,
Abraham G
The Rho kinase (ROCK) inhibitor Y-27632 reduces the beta2-adenoreceptor
density but enhance cAMP
formation in primary equine bronchial epithelial cells.
Eur J Pharmacol 2021; 907:174323
Schoeller C, Hoffmann S, Adolph S, Regenthal
R, Abraham G
Expression of muscarinic acetylcholine receptors in turkey cardiac
chambers
Res Vet Sci 2021; 136:602-608
Schulz-Siegmung M, Aigner A
Nucleic acid delivery with extracellular vesicles.
Adv Drug Deliv Rev 2021; 173: 89-111
Jugel W, Aigner A, Michen
S, Hagstotz A, Ewe A, Appelhans D, Schackert G,
Temme A, Tietze S
Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated
Poly(Propylene Imine)-Based Polyplexes
Inhibits Growth of PSCA-Positive Tumors.
Pharmaceutics 2021; 13(5):676
Kemper M, Schiecke A, Maar H, Nikulin S,
Poloznikov A, Galatenko V, Tachezy M, Gebauer F, Lange T, Riecken K,
Tonevitsky A, Aigner A, Izbicki J, Schumacher U,
Wicklein D
Integrin alpha-V is an important driver in pancreatic adenocarcinoma
progression.
J Exp Clin Cancer Res 2021; 40(1): 214
Kubczak M, Michlewska S, Bryszewska M, Aigner
A , Ionov M
Nanoparticles for local delivery of siRNA in lung therapy.
Adv Drug Deliv Rev 2021; 179: 114038
Lewis CA, Mueller K, Zsido RG, Reinelt J, Regenthal
R, Okon-Singer H, Forbes EE, Villringer A, Sacher J
A single dose of escitalopram blunts the neutral response in the
thalamus and caudate during monetary loss.
J Psychiatry Neurosci 2021; 46(3): 319-327
Molloy EN, Mueller K, Beinhölzl N,
Blöchl M, Piecha FA, Pampel A, Steele CJ, Scharrer U, Zheleva
G, Regenthal R, Sehm B, Nikulin VV, Möller
HE, Villringer A, Sacher J
Modulation of premotor cortex response to sequence motor learning
during escitalopram intake.
J Cereb Blood Flow Metab 2021; 41(6): 1449-1462
Molloy EN, Zsido RG, Piecha FA,
Beinhölzl N, Scharrer U, Zheleva G, Regenthal R,
Sehm B, Nikulin VV, Möller HE, Villringer A, Sacher J, Mueller
K
Decreased thalamo-cortico connectivity during an implicit sequence
motor learning task and 7 days escitalopram intake.
Sci Rep 2021; 11(1): 15060
Nazarova I, Slyusarenko M, Sidina E,
Nikiforova N, Semiglazov V, Semiglazova T, Aigner A,
Rybakov E, Malek A
Evalution of Colon-Specific Plasma Nanovesicles as New Markers of
Colorectal Cancer.
Cancers (Basel) 2021; 13(15):3905
O Callagham C, Hezemans FH, Ye R, Rua C,
Jones PS, Murley AG, Holland N, Regenthal R,
Tsvetanov KA, Wolpe N, Barker RA, Williams-Gray CH,
Robbins TW, Passamonti L, Rowe JB
Locus coeruleus integrety and the effect of atomoxetine on response
inhibition in Parkinsons disease.
Brain 2021; 144: 2513-2526
Offermann A,
Kang D, Watermann C, Weingart A, Hupe MC, Saraji A, Stegmann-Frehse J,
Kruper R, Schüle R, Pantel K, Taubert H, Duensing S, Culig Z, Aigner
A,
Klapper W, Jonigk D, Kühnel PM, Merseburger AS,
Kirfel J, Sailer V, Perner S
Analysis of tripartite motif (TRIM) family gene expression in prostate
cancer bone metastases.
Carcinogenesis 2021; 42(12): 1475-1484
Schellenberg LM, Bonicelli J, Hochheim I, Regenthal
R, Abraham G
Corrigendum to "Presence and function of beta-adrenergic receptors in
primary equine bronchial epithelia cells"
Pulm Pharmacol Ther 2021; 71:102093
Schoeller C, Hoffmann S, Adolph S, regenthal
R, Abraham G
Corrigendum to "Expression of muscarinic acetylcholine receptors in
turkey cardiac chambers
Res Vet Sci 2021; 141: 145
Schreyer
L, Mittermeier C, Franz MJ, Meier MA, Martin DE, Maier KC, Huebner K,
Schneider-Stock R, Singer S, Holzer K, Fischer D, Ribback S, Liebl B,
Gudermann T, Aigner A, Muehlich S
Tetrascrition Factors (MRTFs), Controls HCC Growth and Senescence
Cancers (Basel) 2021; 13(21):5373
Zhukovsky P, Morein-Zamir S, Ziauddeen H,
Fernandez-Egea E, Meng C, Regenthal R, Sahakian BJ,
Bullmore ET, Robbins TW, Dalley JW, Ersche KD
Prefrontal Cortex Activation and Stopping Performance Underlie the
Beneficial Effects of Atomoxetine on Response Inhibition in Healthy
Volunteers and Those With Cocoain Use Disorder
Biol Psychiatry Cogn Neurosci Neuroimaging 2021;
|